Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age-related diseases. It is developing a highly precise, patent-pending, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces the negative effects of aging pathologies and alsoextends the median lifespan and survival.Oisin Biotechnologies was founded in 2014 and is headquartered in Seattle, Washington.

Health Care

Biotechnology

Oisin Biotechnologies

Matthew Scholz

Stephen Hilbert

Kevin Perrott

John Lewis

Hank Garcia

Eric Garcia

Alexandre R. Gingras

Oisin Biotechnologies

Org chart

Teams

Similar companies